Federal prosecutors in Massachusetts say British drug maker GlaxoSmithKline PLC will pay $750 million to settle allegations that its subsidiary manufactured and sold adulterated drugs, including the popular antidepressant Paxil.
U.S. Attorney Carmen Ortiz on Tuesday announced that GlaxoSmithKline has agreed to settle civil and criminal charges related to the subsidiary in Puerto Rico. Ortiz said the London-based company will pay $150 million in criminal fines and $600 million in civil penalties.
GlaxoSmithKline to pay $750 million in pill case
The Supreme Court on May 4 reinstated mail-order access to the widely used abortion drug mifepristone,...
At the MAHA Institute's "Mental Health & Overmedicalization Summit" in the nation's capital, the Health and...
Three people have died in an outbreak of a dangerous respiratory virus on a cruise ship...
